ADVANCE-D Programme for men convicted of domestic abuse serving a community sentence
| ISRCTN | ISRCTN95692133 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN95692133 |
| IRAS number | 328020 |
| Secondary identifying numbers | CPMS 61731, IRAS 328020, NIHR154546 |
- Submission date
- 01/05/2024
- Registration date
- 02/05/2024
- Last edited
- 03/12/2024
- Recruitment status
- Recruiting
- Overall study status
- Ongoing
- Condition category
- Mental and Behavioural Disorders
Plain English Summary
Background and study aims
40% of men convicted for domestic abuse have problems with alcohol or drugs. Despite this, official group work programmes are unavailable for these men in probation services. Domestic abuse costs the UK £66 billion each year. These costs could be reduced if suitable domestic abuse programmes were provided during probation.
Who can participate?
Adult (18+) men serving a community sentence or post imprisonment on license for intimate partner violence towards a female current or ex-partner.
What does the study involve?
32 areas in the UK will be allocated by chance to provide either ADVANCE-D (16 areas) or their usual services (16 areas) to men on probation or parole for domestic abuse. 450 men will be invited to take part in the study within two weeks of being mandated by the court to a community sentence for domestic abuse. All support will be provided by probation staff in England and Wales, and by criminal justice social workers in Scotland. Men and women will be interviewed separately by researchers at the start of the study, and 4 and 12 months later. 4 and 12 months after men are allocated to ADVANCE-D or usual probation services, their use of domestic abuse will be compared. Men in both groups will also be asked about their substance use, health and service use. The men's current or ex-female partners will also be about their own health and service use and about any domestic abuse from their partner. Consent will be obtained to check participants’ health and domestic abuse status over the long term. This will be done by tracking these men and women in health, social services, police and criminal justice data 2 years after the study starts. This will allow the research team to work out what works best to reduce domestic abuse - ADVANCE-D or the usual support offered by probation.
What are the possible benefits and risks of participating?
The study will help to show whether the new intervention helps men who use substances reduce their abusive and violent behaviour towards their female partners. It is hoped that if this happens, it will improve the well-being of their partners and children. To ensure that the women and their children are safe, staff from the substance use treatment service and the women’s support service worker will talk to each other regularly to share information that relates to the women’s safety and risk. Participating in the study could improve relationships and improve the well-being of women and children in the future. The feedback received from both men and their current or ex-female partners will help to show whether the intervention and the study can be done. All participants are given the opportunity to get support for their relationship and are provided with a range of national and local contact numbers and services that will be able to help.
Where is the study run from?
King’s College London (UK), University of Edinburgh (UK), University of Manchester (UK), Cardiff University (UK)
When is the study starting and how long is it expected to run for?
November 2023 to October 2027
Who is funding the study?
National Institute for Health and Care Research (NIHR) (UK)
Who is the main contact?
Prof. Gail Gilchrist Gail.Gilchrist@kcl.ac.uk
Contact information
Scientific, Principal Investigator
4 Windsor Walk, Denmark Hill, Addiction Sciences Building, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London
London
SE5 8BB
United Kingdom
 ORCID ID |
0000-0002-5616-6283 |
|---|---|
| Phone | +44 (0)20 7848 0076 |
| gail.gilchrist@kcl.ac.uk |
Public
4 Windsor Walk, Denmark Hill, Addiction Sciences Building, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King's College London
London
SE5 8BB
United Kingdom
| ORCID ID |
0000-0001-8206-9922 |
|---|---|
| Phone | +44 (0)20 7848 0076 |
| steven.parkes@kcl.ac.uk |
Study information
| Study design | Multicentre cluster-randomized controlled trial with internal pilot |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Cluster randomised trial |
| Study setting(s) | Built environment/local authority, Internet/virtual, Medical and other records, Telephone |
| Study type | Treatment |
| Participant information sheet | Not available in web format, please use the contact details to request a patient information sheet |
| Scientific title | A UK multi-centre cluster randomised control trial, with an internal pilot, of the ADVANCE-Digitally supported perpetrator intervention compared to community justice offender management (1:1), to reduce intimate partner violence (IPV), for men convicted of IPV who misuse substances |
| Study acronym | ADVANCE-D |
| Study hypothesis | To conduct a UK multi-centre cluster-randomised controlled trial, with an internal pilot of the ADVANCE-Digitally supported perpetrator intervention compared to community justice offender management (1:1), to reduce intimate partner violence (IPV), for men convicted of IPV who misuse substances. |
| Ethics approval(s) |
1. Approved 20/03/2024, His Majesty’s Prison and Probation Services (HMPPS) National Research Committee (102 Petty France, London, SW1H 9AJ, United Kingdom; -; National.Research@justice.gov.uk), ref: 2023-262 2. Approved 18/07/2024, NHS West of Scotland Research Ethics Service (Ground Floor Ward 11, Dykebar Hospital, Grahamston Road, Paisley, PA2 7DE, United Kingdom; +44 141 314 0212; WoSREC1@ggc.scot.nhs.uk), ref: 24/WS/0068 |
| Condition | Reduce intimate partner violence (IPV) for men convicted of IPV who misuse substances |
| Intervention | Current interventions as of 16/10/2024: 32 probation delivery units (PDU)/Justice Social Work Teams (JSWT) will be randomised (1:1) to deliver ADVANCE-D or usual community justice offender management (CJOM). The PDU/JSWT and researchers will be blinded to (not know which) treatment allocation until all 14 men from their cluster have been recruited and baselined and researchers have recruited and baselined the (ex)-partners. ADVANCE-D proposes that behaviour change is facilitated by increasing understanding of the function of abusive behaviours and the contribution made by substance misuse and gendered attitudes. It highlights individual risks for intimate partner violence (IPV), including substance misuse, poor emotional regulation, and poor stress coping. It teaches men how to reduce these risks by promoting self-regulation and personal goal-setting. ADVANCE-D is a 33-session (14-week) programme (+ refresher session 4 weeks later) delivered in-person, remotely or hybrid. It includes a 1:1 goal-setting session; a welcome-to-group preparation session; 6 group sessions [these are the 8 core sessions]; and 12 self-directed website sessions with a digital coach (avatar) to recap and practise skills learned in the group each followed by 1:1 coaching sessions with a facilitator (12 weekly coaching sessions in total). It is delivered by 2 facilitators (ideally one female), trained in supervising PP/JSW. To manage risk, 4 case management meetings are scheduled with the ISS. Men offered ADVANCE-D can receive concomitant support for substance misuse. _____ Previous interventions: 32 probation delivery units (PDU)/Justice Social Work Teams (JSWT) will be randomised (1:1) to deliver ADVANCE-D or usual community justice offender management (CJOM) using an online randomisation system divided (stratified) by probation region/JSW area, managed by King’s Clinical Trials Unit (KCTU). The PDU/JSWT and researchers will be blinded to (not know which) treatment allocation until all 14 men from their cluster have been recruited and baselined and researchers have recruited and baselined the (ex)partners. ADVANCE-D proposes that behaviour change is facilitated by increasing understanding of the function of abusive behaviours and the contribution made by substance misuse and gendered attitudes. It highlights individual risks for intimate partner violence (IPV), including substance misuse, poor emotional regulation, and poor stress coping. It teaches men how to reduce these risks by promoting self-regulation and personal goal-setting. ADVANCE-D is a 33-session (14-week) programme (+ refresher session 4 weeks later) delivered in-person, remotely or hybrid. It includes a 1:1 goal-setting session; a welcome-to-group preparation session; 6 group sessions [these are the 8 core sessions]; and 12 self-directed website sessions with a digital coach (avatar) to recap and practise skills learned in the group each followed by 1:1 coaching sessions with a facilitator (12 weekly coaching sessions in total). It is delivered by 2 facilitators (ideally one female), trained in supervising PP/JSW. To manage risk, 4 case management meetings are scheduled with the ISS. Men offered ADVANCE-D can receive concomitant support for substance misuse. |
| Intervention type | Behavioural |
| Primary outcome measure | Current primary outcome measure as of 30/07/2024: Intimate partner violence (IPV) perpetration reduction for men who misuse substances subject to probation/CJSW supervision measured using the (Adapted) Abusive Behavior Inventory (ABI) in the past 4 months at 12 months post-baseline _____ Previous primary outcome measure: Intimate partner violence (IPV) perpetration reduction for men who misuse substances subject to probation/CJSW supervision measured using the Abusive Behavior Inventory (ABI) in the past 4 months at 12 months post-baseline |
| Secondary outcome measures | Current secondary outcome measures as of 16/10/2024: 1. Intimate partner violence (IPV) victimisation, experienced by partners, measured using the (Adapted) Revised Abusive Behavior Inventory (ABI-R) (women only) at 4 and 12 months post-baseline 2. Other IPV outcomes: (Adapted) Revised Controlling Behaviors Scale (CBS-R), technology facilitated abuse, stalking/harassment, locked in, using children against partner, feeling of safety (women only), (Adapted) Intimate Partner Violence Responsibility Attribution Scale (IPVRAS) (men only); well-being: Patient Health Questionnaire (PHQ-9), Generalised Anxiety Disorder symptoms (GAD-7), Primary Care PTSD Screen for DSM-5 (PC-PTSD-5), Propensity for Abusiveness Scale (PAS) [anger subscale] (men only); self-control: Brief Self-Control Scale (BSCS) (men only); substance use: Treatment Outcomes Profile (partial), Alcohol Use Disorder Identification Test (AUDIT), Drug Use Disorder Identification Test (DUDIT); quality of life: EQ-5D-5L for participants and their current or ex-partners. 3. Implementation, mechanisms of impact, and contextual factors of delivering ADVANCE-D measured using a nested process evaluation with participants and practitioners at 4 and 12 months post-baseline 4. Children’s well-being as reported by men and their (ex)-partners at 4 and 12 months post-baseline. 5. Comparison of costs and outcomes of ADVANCE-D with CJOM over and above usual CJOM using cost-consequences analysis at 4 and 12 months post-baseline 6. Health, social services, and criminal justice outcomes between men offered ADVANCE-D with CJOM or usual CJOM and their (ex)-partners measured using data linkage of participants to routine databases and electronic records at 24 months post-baseline _____ Previous secondary outcome measures as of 30/07/2024: 1. Intimate partner violence (IPV) victimisation, experienced by partners, measured using the (Adapted) Revised Abusive Behavior Inventory (ABI-R) (women only) at 4 and 12 months post-baseline 2. Other IPV outcomes (Adapted) Revised Controlling Behaviors Scale (CBS-R), technology facilitated abuse, stalking/harassment, locked in and using children against partner), well-being (PHQ-9; GAD-7; Primary Care PTSD Screen for DSM-5 (PC-PTSD-5); Propensity for Abusiveness Scale [anger subscale] (men only); self control (Brief Self-Control Scale (men only); children’s well-being; substance use (Treatment Outcomes Profile (partial)) and quality of life (EQ-5D-5L) for participants and their current or ex-partners. 3. Implementation, mechanisms of impact, and contextual factors of delivering ADVANCE-D measured using a nested process evaluation with participants and practitioners at 4 and 12 months post-baseline 4. Children’s well-being as reported by men and their (ex)-partners at 4 and 12 months post-baseline. 5. Comparison of costs and outcomes of ADVANCE-D over and above usual CJOM using cost-consequences analysis at 4 and 12 months post-baseline 6. Health, social services, and criminal justice outcomes between men offered ADVANCE-D or usual CJOM and their (ex)-partners measured using data linkage of participants to routine databases and electronic records at 24 months post-baseline _____ Previous secondary outcome measures: 1. Intimate partner violence (IPV) victimisation, experienced by partners, measured using the Revised Abusive Behavior Inventory (ABI-R) (women only) at 4 and 12 months post-baseline 2. Other IPV outcomes (Controlling Behaviours Scale (partial), technology-facilitated abuse, locked in, stalking and using children against partner), well-being (PHQ-9; GAD-7; PC-PTSD-5; PAS [anger subscale] (men only)); BSCS (men only); substance use (TOPS) and quality of life (EQ-5D-5L) for participants and their current or ex-partners at 4 and 12-months post-baseline 3. Implementation, mechanisms of impact, and contextual factors of delivering ADVANCE-D measured using a nested process evaluation with participants and practitioners at 4 and 12 months post-baseline 4. Comparison of costs and outcomes of ADVANCE-D over and above usual CJOM using cost-consequences analysis at 4 and 12 months post-baseline 5. Health, social services, and criminal justice outcomes between men offered ADVANCE-D or usual CJOM and their (ex)-partners measured using data linkage of participants to routine databases and electronic records at 24 months post-baseline |
| Overall study start date | 01/11/2023 |
| Overall study end date | 31/10/2027 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | Both |
| Target number of participants | Planned Sample Size: 450; UK Sample Size: 450 |
| Participant inclusion criteria | Current inclusion criteria as of 03/12/2024: For participants (men): 1. Adult (18+) men serving a community sentence or post imprisonment on license for IPV towards a female current or ex-partner. 2. Drugs or alcohol linked to criminogenic need recorded on OASys (England) or LS/CMI (Scotland). 3. Able to provide contact details for (ex)-partner – victim of index crime will be invited to participate in the trial. 4. Able to communicate in and understand English for the purpose of research interviews. For current or ex-partners (women): 1. Adult (18+) women who have a current or ex-partner participating in the trial that was sentenced for IPV towards them. 2. Lives in the UK. 3. Able to communicate in and understand English for the purpose of research interviews. _____ Previous inclusion criteria as of 16/10/2024: For participants (men): 1. Adult (18+) men serving a community sentence or post imprisonment on license for IPV towards a female current or ex-partner. 2. Drugs and alcohol linked to criminogenic need recorded on OASys (England) or LS/CMI (Scotland). 3. Able to provide contact details for (ex)-partner – victim of index crime will be invited to participate in the trial. 4. Able to communicate in and understand English for the purpose of research interviews. For current or ex-partners (women): 1. Adult (18+) women who have a current or ex-partner participating in the trial that was sentenced for IPV towards them. 2. Lives in the UK. 3. Able to communicate in and understand English for the purpose of research interviews. _____ Previous inclusion criteria as of 30/07/2024: For participants (men): 1. Adult (18+) men serving a community sentence or post imprisonment on license for IPV towards a female current or ex-partner 2. Drugs and alcohol linked to criminogenic need recorded on OASys (England) or LSCMI (Scotland) 3. Alcohol and/or drug use not daily or almost daily in the substance use screen (England) or SARA V3 in Scotland 4. Not suitable for existing probation-based perpetrator interventions 5. Not involved with the private family law court 6. Able to provide contact details for (ex)-partner – victim of index crime will be invited to participate in the trial 7. Able to communicate in and understand English for the purpose of research interviews. ADVANCE-D is available in Polish, Romanian, Urdu, or Panjabi to allow men to complete it in their first language. 8. Digital literacy assessed using the eHealth Literacy Scale (eHEALS) (ineligible if answers ‘strongly disagree’ to all 8 items) For current or ex-partners (women): 1. Adult (18+) women who have a current or ex-partner participating in the trial that was sentenced for IPV towards them 2. Lives in the UK 3. Able to communicate in and understand English for the purpose of research interviews. ADVANCE-D is available in Polish, Romanian, Urdu, or Panjabi to allow men to complete it in their first language. _____ Previous inclusion criteria: For participants (men): 1. Adult (18+) men serving a community sentence or post imprisonment on license for IPV towards a female current or ex-partner 2. Alcohol or drug misuse assessed via the Spousal Assault Risk Assessment (SARA) and the Offender Assessment System completed by Probation Practitioners (PP) or the Level Service/Case Management Inventory (LSCMI) completed by JSW 3. Not suitable for an existing probation perpetrator intervention 4. Able to provide contact details for (ex)-partner 5. Able to communicate in and understand English,Polish,Romanian,Urdu,or Panjabi (languages that the ADVANCE-D Programme is available in) 6. Digitally literate - digital literacy assessed using the eHealth Literacy Scale (eHEALS) For current or ex-partners (women): 1. Adult (18+) women who have a current or ex-partner participating in the trial 2. Lives in the UK 3. Able to communicate in and understand English,Polish,Romanian,Urdu,or Panjabi (languages that the ADVANCE-D Programme is available in) |
| Participant exclusion criteria | Current exclusion criteria as of 02/12/2024: For participants (men): 1. Suitable for or attending an existing probation-based perpetrator intervention. 2. Man involved with the private family law court. 3. History of sex offences against children. 4. Answers ‘strongly disagree’ to all 8 items on the eHealth Literacy Scale (eHEALS). 5. Substance use impairs ability to take part in the trial (based on practitioner assessment of frequency/amount of substance use, impact of substance use on daily activities/functioning, and health, social, legal or financial problems as a result of substance use) assessed using the substance use screen (England) or SARA V3 (Scotland). For current or ex-partners (women): 1. Current order preventing her from contacting current or ex male partner recruited to the trial. 2. Other safety concerns that may put the male partner at risk. These will be considered on a case-by-case basis by the research team and the clinical team e.g. where both participants share a mobile phone number, the female participant has a court case pending for IPV or there is a child protection hearing pending. 3. Female partner discloses that there is an order preventing her male current or ex-partner from contacting her (i.e. contradicting what he has said in his screening interview). In such cases the man would not be withdrawn, unless the clinical team felt there was an increased risk to either party in his continuing in the study. _____ Previous exclusion criteria as of 16/10/2024: For participants (men): 1. Suitable for or attending an existing probation-based perpetrator intervention. 2. Man involved with the private family law court. 3. History of sex offences against children. 4. Answers ‘strongly disagree’ to all 8 items on the eHealth Literacy Scale (eHEALS). 5. Alcohol and/or drug use ‘daily’ or ‘almost daily’ in the substance use screen (England) or substance use functional impairment based on the SARA V3 (Scotland). For current or ex-partners (women): 1. Current order preventing her from contacting current or ex male partner recruited to the trial. 2. Other safety concerns that may put the male partner at risk. These will be considered on a case-by-case basis by the research team and the clinical team e.g. where both participants share a mobile phone number, the female participant has a court case pending for IPV or there is a child protection hearing pending. 3. Female partner discloses that there is an order preventing her male current or ex-partner from contacting her (i.e. contradicting what he has said in his screening interview). In such cases the man would not be withdrawn, unless the clinical team felt there was an increased risk to either party in his continuing in the study. _____ Original exclusion criteria: For participants (men): 1. Suitable for or attending an existing probation-based perpetrator intervention 2. Man involved with the private family law court 3. History of sex offences against children For current or ex-partners (women): 1. Current order preventing her from contacting current or ex male partner recruited to the trial. 2. Other safety concerns that may put the male partner at risk. These will be considered on a case-by-case basis by the research team and the clinical team e.g. where both participants share a mobile phone number,the female participant has a court case pending for IPV or there is a child protection hearing pending. 3. Female partner discloses that there is an order preventing her male current or ex-partner from contacting her (i.e. contradicting what he has said in his screening interview). In such cases the man would not be withdrawn,unless the clinical team felt there was an increased risk to either party in his continuing in the study. |
| Recruitment start date | 02/12/2024 |
| Recruitment end date | 31/10/2026 |
Locations
Countries of recruitment
- United Kingdom
Study participating centres
Manchester
M4 4AH
United Kingdom
Preston
PR2 2YB
United Kingdom
Edinburgh
EH3 9AR
United Kingdom
Sponsor information
University/education
Room 8.11, 8th Floor Melbourne House, 44-46 Aldwych
London
WC2B 4LL
England
United Kingdom
| Phone | +44 (0)2078487306 |
|---|---|
| vpri@kcl.ac.uk | |
| Website | https://www.kcl.ac.uk/ |
"ROR" |
https://ror.org/0220mzb33 |
Funders
Funder type
Government
Government organisation / National government
- Alternative name(s)
- National Institute for Health Research, NIHR Research, NIHRresearch, NIHR - National Institute for Health Research, NIHR (The National Institute for Health and Care Research), NIHR
- Location
- United Kingdom
Results and Publications
| Intention to publish date | 31/10/2028 |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not expected to be made available |
| Publication and dissemination plan | Planned publication in a peer-reviewed journal |
| IPD sharing plan | The datasets generated during and/or analysed during the current study are not expected to be made available due to confidentiality. Documents, such as the study protocol, and statistical analysis plan, can be requested from the CI. Prof. Gail Gilchrist Gail.Gilchrist@kcl.ac.uk. |
Editorial Notes
03/12/2024: The inclusion criteria were changed.
02/12/2024: The following changes were made to the study record:
1. The exclusion criteria were updated.
2. The recruitment start date was changed from 11/11/2024 to 02/12/2024.
16/10/2024: The following changes were made to the trial record:
1. The interventions were changed.
2. The secondary outcome measures were changed.
3. The inclusion criteria were changed.
4. The exclusion criteria were changed.
5. The recruitment start date was changed from 01/10/2024 to 11/11/2024.
09/09/2024: The recruitment start date was changed from 01/09/2024 to 01/10/2024.
30/07/2024: The following changes were made to the trial record:
1. The ethics approval (2) was added.
2. The primary outcome measure was changed.
3. The secondary outcome measures were changed.
4. The inclusion criteria were changed.
5. The recruitment start date was changed from 27/05/2024 to 01/09/2024.
01/05/2024: Study's existence confirmed by the National Institute for Health and Care Research (NIHR) (UK).
